Literature DB >> 9028348

Nephrotic syndrome as a complication of immune tolerance in hemophilia B.

B M Ewenstein, C Takemoto, I Warrier, J Lusher, P Saidi, J Eisele, L J Ettinger, D DiMichele.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9028348

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  18 in total

Review 1.  Gene therapy for hemophilia: what does the future hold?

Authors:  Bhavya S Doshi; Valder R Arruda
Journal:  Ther Adv Hematol       Date:  2018-08-27

2.  AAV liver expression of FIX-Padua prevents and eradicates FIX inhibitor without increasing thrombogenicity in hemophilia B dogs and mice.

Authors:  Julie M Crudele; Jonathan D Finn; Joshua I Siner; Nicholas B Martin; Glenn P Niemeyer; Shangzhen Zhou; Federico Mingozzi; Clinton D Lothrop; Valder R Arruda
Journal:  Blood       Date:  2015-01-07       Impact factor: 22.113

3.  A survey of the management of newborns with severe hemophilia in Canada.

Authors:  Paul C Moorehead; Jamie Ray; Nicholas J Barrowman; Brigitte Lemyre; Robert Klaassen
Journal:  Paediatr Child Health       Date:  2013-04       Impact factor: 2.253

4.  Recurrent episodes of anaphylaxis in a patient with haemophilia B: a case report.

Authors:  Margherita Mauro; Elisa Bonetti; Rita Balter; Giovanni Poli; Simone Cesaro
Journal:  Blood Transfus       Date:  2016-04-28       Impact factor: 3.443

Review 5.  Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation.

Authors:  David W Scott; Jay N Lozier
Journal:  Br J Haematol       Date:  2011-11-07       Impact factor: 6.998

Review 6.  Immune tolerance therapy for haemophilia.

Authors:  A Y Ho; S E Height; M P Smith
Journal:  Drugs       Date:  2000-09       Impact factor: 9.546

7.  Successful management of factor IX inhibitor-associated nephrotic syndrome in a hemophilia B patient.

Authors:  Priya Verghese; Stephen Darrow; Margaret H Kurth; Robyn C Reed; Youngki Kim; Susan Kearney
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

8.  Survey of the anti-factor IX immunoglobulin profiles in patients with hemophilia B using a fluorescence-based immunoassay.

Authors:  B Boylan; A S Rice; A T Neff; M J Manco-Johnson; C L Kempton; C H Miller
Journal:  J Thromb Haemost       Date:  2016-09-17       Impact factor: 5.824

9.  Neutralizing antibodies to therapeutic enzymes: considerations for testing, prevention and treatment.

Authors:  Jinhai Wang; Jay Lozier; Gibbes Johnson; Susan Kirshner; Daniela Verthelyi; Anne Pariser; Elizabeth Shores; Amy Rosenberg
Journal:  Nat Biotechnol       Date:  2008-08       Impact factor: 54.908

Review 10.  Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.

Authors:  Davide Matino; Michael Makris; Kerry Dwan; Roberto D'Amico; Alfonso Iorio
Journal:  Cochrane Database Syst Rev       Date:  2015-12-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.